Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

Press releases published on May 8, 2026

May 8, 2026

The Artificial Intelligence (AI) in Biopharmaceuticals Market to USD 8.77 billion by 2030, growth rate of 33.1%.

Indeterminate EIN Presswire

May 8, 2026

Antivenom Market Projected to Reach $2.91 Billion by 2030 - Comprehensive Report from The Business Research Company

Indeterminate EIN Presswire

May 8, 2026

Androgenetic Alopecia Treatment Market: Application, Industry & Regional Analysis with Segment Forecasts to 2030

Indeterminate EIN Presswire

May 8, 2026

NUVINI GROUP’S CHIEF AI OFFICER PHOEBE WANG SELECTED AS SPEAKER AT SUPERRETURN CFO/COO NORTH AMERICA IN CHICAGO

Indeterminate EIN Presswire

May 8, 2026

Crypto News: AlphaPepe Advances Toward Q2 Exchange Listing While XRP Price Prediction Targets $10

Indeterminate GlobeNewswire

May 8, 2026

argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG

Indeterminate GlobeNewswire

May 8, 2026

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

Indeterminate GlobeNewswire

May 8, 2026

Acronis y NetFusion #TeamUp se asocian para lanzar un laboratorio de robótica STEAM para estudiantes vulnerables en Costa Rica

Indeterminate GlobeNewswire

May 8, 2026

SalesCloser Announces Collaboration with Twilio to Accelerate Customer Deployments

Indeterminate GlobeNewswire

May 8, 2026

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 8, 2026

Azalea Therapeutics Announces Late-Breaking Oral Presentation at ASGCT Annual Meeting Demonstrating First-in-Primate In Vivo TRAC-CAR T Cell Engineering

Indeterminate GlobeNewswire

May 8, 2026

NVIDIA Names Suzanne Nora Johnson to Board of Directors

Indeterminate GlobeNewswire

May 8, 2026

Capnos Legura 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying

Indeterminate GlobeNewswire

May 8, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 8, 2026

Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs

Indeterminate GlobeNewswire

May 8, 2026

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 8, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 8, 2026

Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Indeterminate GlobeNewswire

May 8, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

May 8, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire